Opportunities and challenges in application of artificial intelligence in pharmacology.
Mandeep KumarT P Nhung NguyenJasleen KaurThakur Gurjeet SinghDivya SoniRandhir SinghPuneet KumarPublished in: Pharmacological reports : PR (2023)
Artificial intelligence (AI) is a machine science that can mimic human behaviour like intelligent analysis of data. AI functions with specialized algorithms and integrates with deep and machine learning. Living in the digital world can generate a huge amount of medical data every day. Therefore, we need an automated and reliable evaluation tool that can make decisions more accurately and faster. Machine learning has the potential to learn, understand and analyse the data used in healthcare systems. In the last few years, AI is known to be employed in various fields in pharmaceutical science especially in pharmacological research. It helps in the analysis of preclinical (laboratory animals) and clinical (in human) trial data. AI also plays important role in various processes such as drug discovery/manufacturing, diagnosis of big data for disease identification, personalized treatment, clinical trial research, radiotherapy, surgical robotics, smart electronic health records, and epidemic outbreak prediction. Moreover, AI has been used in the evaluation of biomarkers and diseases. In this review, we explain various models and general processes of machine learning and their role in pharmacological science. Therefore, AI with deep learning and machine learning could be relevant in pharmacological research.
Keyphrases
- artificial intelligence
- big data
- machine learning
- deep learning
- electronic health record
- healthcare
- clinical trial
- endothelial cells
- public health
- drug discovery
- convolutional neural network
- study protocol
- palliative care
- phase ii
- radiation therapy
- clinical decision support
- early stage
- stem cells
- open label
- phase iii
- double blind
- mesenchymal stem cells
- adverse drug
- locally advanced
- health information